Skip to content

Turning innovation into tax advantage and competitive edge

We advise research centres, technology institutes, universities with commercial activities and companies with R&D departments on maximising tax incentives, protecting intellectual output and securing national and European public funding.

8.610
active companies in Spain
128.434
registered workers (SS)
3.0B€
annual revenue (INE)
46,2%
5-year survival rate
15,8%
sector gross margin
11,6%
EU business share

Source: cifex · Seguridad Social · INE EEE · INE DIRCE

Art. 35
LIS: up to 42% deduction on incremental R&D expenditure
40%
social security rebate on employer contributions for dedicated researchers
15M€+
in R&D grants and deductions managed annually

Spain’s research and development sector groups 8,610 active companies and employs 128,434 workers registered with Social Security, with aggregate revenues of €3.0 billion and a gross margin of 15.8%. Beyond these figures, the sector acts as an engine of technology transfer across the wider economy: its 11.6% share of the European R&D market positions Spain as a significant player in the continental race for innovation. The five-year survival rate of 46.2% is the lowest of any sector we advise — a reflection of the inherent difficulty of research-based business models, with their long cycles, technical uncertainty and dependence on public funding — and of the critical importance of a correctly designed legal and tax structure from day one.

Spain possesses a solid — though underutilised — system of public incentives for research and development. The Article 35 LIS deductions are, alongside the Article 23 Patent Box, the most powerful fiscal instruments available to companies with significant innovation activity: in years where R&D expenditure exceeds the two-year average, the marginal deduction on incremental spending reaches 42%, and unused deductions can be refunded or carried forward up to 50% of gross tax liability. Despite these incentives, take-up among Spanish companies remains low — largely due to lack of awareness or inadequate technical documentation.

At BMC we work with R&D departments of industrial groups, private technology centres, university spin-offs and deep-tech startups to identify, quantify and defend all available deduction bases. Our method combines fiscal expertise with a genuine understanding of technology projects: we review projects alongside technical teams, classify activities according to the Frascati Manual criteria and AEAT doctrine, prepare the technical memorandum for MINECO reasoned reports and build the documentary file needed to defend the deduction in an audit. Where applicable, we coordinate the application for deduction monetisation with the AEAT to recover cash even in years with insufficient tax liability.

Grant management and public funding is the other pillar of our service. We accompany clients from identifying the right funding call through to economic and technical justification before the funding body, covering application drafting, project term negotiation and management of advances and special conditions. At the international level — where Spain’s 11.6% European share opens meaningful doors to EU programmes — we assist Spanish companies in submitting proposals to Horizon Europe, particularly through the EIC Accelerator and EIC Pathfinder instruments, and in establishing European R&D consortia, including negotiation of consortium agreements and confidentiality and results exploitation agreements.

Glossary

Key Sector Terms

Accelerated Depreciation in Spain (Amortización Fiscal Acelerada)

Accelerated depreciation (amortización fiscal acelerada) in Spain allows companies to deduct a higher proportion of an asset's cost in the early years of its useful life for Corporate Tax purposes, reducing taxable income sooner than straight-line accounting depreciation would permit. Spain offers both statutory accelerated tables and specific regimes for SMEs, newly hired personnel, and R&D assets.

EU AI Act

The EU Artificial Intelligence Act (Regulation EU 2024/1689) is the world's first comprehensive legal framework for artificial intelligence. It classifies AI systems by risk level, imposes obligations on developers, deployers, and importers, and establishes penalties of up to €35 million or 7% of global turnover for the most serious violations. It entered into force in August 2024 with phased compliance deadlines through 2027.

Annual Accounts (Cuentas Anuales)

Cuentas Anuales are the statutory annual financial statements that all Spanish companies must prepare, approve, and deposit at the Commercial Registry each year. They include the balance sheet, income statement, statement of changes in equity, cash flow statement (for larger companies), and notes.

Arbitration and Mediation in Spain

Spain has a well-developed framework for alternative dispute resolution (ADR). Arbitration is governed by Ley 60/2003 de Arbitraje (based on the UNCITRAL Model Law) and provides a binding, private process with enforceable awards. Mediation in civil and commercial matters is regulated by Ley 5/2012. Spain is a signatory to the New York Convention (1958), enabling international enforcement of Spanish arbitral awards in 170+ countries.

Autónomo — Self-Employed in Spain

An autónomo is a self-employed individual in Spain who carries out an economic activity on their own account. Autónomos must register with the AEAT for tax purposes and with Social Security (RETA regime), pay quarterly income tax instalments and VAT returns, and pay monthly Social Security contributions.

Balance Sheet in Spain

The balance sheet (balance de situación) is a statutory financial statement that presents a company's assets, liabilities, and shareholders' equity at a specific point in time. In Spain, it is a mandatory component of the annual accounts (cuentas anuales) prepared under the Plan General Contable (Spanish GAAP) and filed at the Commercial Registry.

FAQ

Frequently asked questions

Article 35 LIS distinguishes two categories: the R&D deduction, which applies to activities seeking new knowledge or involving scientific or technological uncertainty, with a base rate of 25% (rising to 42% when expenditure exceeds the two-year average); and the technological innovation (IT) deduction at 8%, covering less novel activities that nonetheless represent a significant advance over the state of the art. Correctly classifying each project is decisive for maximising the deductible base and successfully withstanding an AEAT audit.
Reasoned reports issued by the Ministry of Science and Innovation (through the State Research Agency) classify projects as R&D or IT for tax purposes and are binding on the AEAT, eliminating the risk of the technical classification being challenged in a tax inspection. While not mandatory, they are strongly recommended for projects with significant deduction bases. The application requires a detailed technical memorandum; we manage the preparation of this documentation and liaise with the Ministry throughout the process.
Article 26 of the Science Act (Law 14/2011) allows companies conducting R&D activities to apply a 40% rebate on employer Social Security contributions for common contingencies of researchers exclusively dedicated to R&D. To apply the rebate, researchers must have documented exclusive dedication and the company must evidence the nature of its activities. This rebate is compatible with the Article 35 LIS deductions, amplifying the total economic benefit of R&D activities.
The public funding ecosystem is extensive: the CDTI offers partially subsidised loans (NEOTEC for innovative startups, business R&D projects), the State Research Agency funds competitive projects (National R&D+I Plan), the autonomous communities have their own calls, and the EU's Horizon Europe programme — with a budget of €95.5 billion for 2021–2027 — is the most significant competitive funding source at European level. Efficient management of these sources demands anticipation: calls have strict timetables and justification documentation is highly demanding.
Collaborative research contracts between companies and public research organisations or universities must precisely regulate ownership of results (intellectual and industrial property), exploitation rights, confidentiality treatment and profit sharing upon commercialisation. The Science Act and the Universities Act establish the applicable framework. Poor contract negotiation can leave a company without the rights needed to commercially exploit the project's results.

Request a personalized consultation

Our experts are ready to analyze your situation and provide tailored solutions.

Call Contact